Advancing the Metabolic Dysfunction-Associated Steatotic Liver Disease Proteome: A Post-Translational Outlook
Genes · 12.03.2025 · 16 (3) · 334
DOI: 10.3390/genes16030334 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Genes, online erschienen am 12.03.2025. Verfasst von Kushan Chowdhury und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Vatche and Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, CA 90095, USA. Hauptthemen laut MEDLINE: Protein Processing, Post-Translational, Proteome, Fatty Liver. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, the Pilot & Feasibility award from the Center for Diabetes and Metabolic Diseases, the Heartland Children’s Nutrition Collaborative.
Abstract (Originalsprache)
Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent liver disorder with limited treatment options. This review explores the role of post-translational modifications (PTMs) in MASLD pathogenesis, highlighting their potential as therapeutic targets. We discuss the impact of PTMs, including their phosphorylation, ubiquitylation, acetylation, and glycosylation, on key proteins involved in MASLD, drawing on studies that use both human subjects and animal models. These modifications influence various cellular processes, such as lipid metabolism, inflammation, and fibrosis, contributing to disease progression. Understanding the intricate PTM network in MASLD offers the potential for developing novel therapeutic strategies that target specific PTMs to modulate protein function and alleviate disease pathology. Further research is needed to fully elucidate the complexity of PTMs in MASLD and translate these findings into effective clinical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Vatche and Tamar Manoukian Division of Digestive Diseases, University of California Los Angeles, Los Angeles, CA 90095, USA.
- Department of Biochemistry and Molecular Biology, Indiana University School of Medicine, Indiana University, Indianapolis, IN 46202, USA.
- Center for Diabetes and Metabolic Diseases, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
- Melvin & Bren Simon Comprehensive Cancer Center, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
ORCID-Profile: Debajyoti Das
Förderung
- NIDDK NIH HHS
- the Pilot & Feasibility award from the Center for Diabetes and Metabolic Diseases
- the Heartland Children’s Nutrition Collaborative
Zitieren
APA
Chowdhury, K., Das, D., & Huang, M. (2025). Advancing the Metabolic Dysfunction-Associated Steatotic Liver Disease Proteome: A Post-Translational Outlook. Genes, 16(3), 334. https://doi.org/10.3390/genes16030334
Vancouver
Chowdhury K, Das D, Huang M. Advancing the Metabolic Dysfunction-Associated Steatotic Liver Disease Proteome: A Post-Translational Outlook. Genes. 2025;16(3):334. doi:10.3390/genes16030334
BibTeX
@article{Chowdhury2025,
author = {Chowdhury, Kushan and Das, Debajyoti and Huang, Menghao},
title = {Advancing the Metabolic Dysfunction-Associated Steatotic Liver Disease Proteome: A Post-Translational Outlook},
journal = {Genes},
year = {2025},
volume = {16},
number = {3},
pages = {334},
doi = {10.3390/genes16030334}
}
EUVIMED